Global Urine in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030
The Urine in Vitro Diagnostics market is projected to grow from USD 22.05 Billion in 2023 to USD 33.65 Billion in 2030, driven by the increasing need for accurate and fast diagnost
- Bonafide Trust
- 31-05-2024
- Pages : 79
- Figures : 79
- Tables : 155
- Region : Global
- Category : Lifescience
- Medical Devices
Urine in vitro diagnostics (IVD) involve the analysis of urine samples to obtain information about various aspects of an individual's health. Urine is a valuable biological fluid that can provide insights into kidney function, metabolic processes, and the presence of certain substances or markers.
The global Urine in Vitro Diagnostics market size is projected to grow from US$ 22050 million in 2023 to US$ 33650 million in 2030; it is expected to grow at a CAGR of 6.2% from 2024 to 2030.
Our publisher’s newest research report, the “Urine in Vitro Diagnostics Industry Forecast” looks at past sales and reviews total world Urine in Vitro Diagnostics sales in 2023, providing a comprehensive analysis by region and market sector of projected Urine in Vitro Diagnostics sales for 2024 through 2030. With Urine in Vitro Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Urine in Vitro Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Urine in Vitro Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Urine in Vitro Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Urine in Vitro Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Urine in Vitro Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Urine in Vitro Diagnostics.
The Urine In Vitro Diagnostics market is driven by the essential role urine analysis plays in assessing various health conditions. In vitro diagnostic devices dedicated to urine testing, such as urinalysis strips, urine chemistry analyzers, and automated urine sediment analyzers, are instrumental in detecting disorders related to the urinary system, diabetes, kidney diseases, and metabolic conditions. The market benefits from the increasing prevalence of such health issues and the need for efficient and cost-effective diagnostic solutions. The simplicity and non-invasiveness of urine sample collection contribute to the widespread adoption of urine in vitro diagnostics, making it a fundamental component of routine medical examinations and disease management.
This report presents a comprehensive overview, market shares, and growth opportunities of Urine in Vitro Diagnostics market by product type, application, key players and key regions and countries.
Market Drivers and Challenges:
Market Drivers:
Increasing incidence of chronic diseases: The rising prevalence of chronic diseases such as diabetes, kidney disease, and urinary tract infections (UTIs) is driving the demand for urine IVD tests.
Advances in technology: The development of new and improved technologies, such as point-of-care testing (POCT) and molecular diagnostics, is increasing the accuracy and convenience of urine IVD tests.
Growing demand for personalized medicine: The need for personalized medicine is driving the demand for urine IVD tests that can provide more accurate and targeted treatment options for patients.
Increasing healthcare spending: The increasing healthcare spending in developed and developing countries is driving the demand for urine IVD tests.
Government initiatives: Government initiatives to improve healthcare infrastructure and increase access to healthcare services are driving the demand for urine IVD tests.
Market Challenges:
High competition: The urine IVD market is highly competitive, with many established players and new entrants vying for market share.
Regulatory challenges: The regulatory environment for urine IVD tests is complex and changing, with new regulations and guidelines being introduced regularly.
Cost constraints: The high cost of urine IVD tests can be a barrier to adoption, particularly in developing countries.
Limited awareness: Limited awareness of the importance of urine IVD tests and their benefits can hinder adoption.
Supply chain disruptions: Supply chain disruptions, such as those caused by the COVID-19 pandemic, can impact the availability of urine IVD tests and supplies.
Technological Developments: The global urine in vitro diagnostics (IVD) market is expected to witness significant technological advancements in the coming years. These advancements are driven by the increasing demand for accurate and timely diagnosis of various diseases, as well as the need for cost-effective and efficient diagnostic solutions.
Molecular Diagnostics
Molecular diagnostics is a rapidly growing segment in the urine IVD market. This technology involves the use of molecular biology techniques to detect and analyze genetic material, such as DNA or RNA, in urine samples. Molecular diagnostics has several advantages, including high sensitivity and specificity, rapid turnaround time, and the ability to detect multiple targets simultaneously.
Point-of-Care (POC) Testing
POC testing is another area of technological development in the urine IVD market. POC testing involves performing diagnostic tests at or near the patient’s bedside, rather than in a central laboratory. This approach has several benefits, including reduced turnaround time, increased patient convenience, and improved patient outcomes.
Liquid Biopsy
Liquid biopsy is a non-invasive diagnostic technique that involves analyzing circulating tumor cells or DNA in urine samples. This technology has the potential to revolutionize the diagnosis and monitoring of cancer, as well as other diseases.
Artificial Intelligence (AI) and Machine Learning (ML)
AI and ML are being increasingly used in the urine IVD market to improve diagnostic accuracy and efficiency. These technologies can be used to analyze large amounts of data, identify patterns, and make predictions about disease diagnosis and treatment.
Other Technological Developments
Other technological developments in the urine IVD market include the use of nanotechnology, biosensors, and microfluidics. These technologies have the potential to improve the sensitivity, specificity, and speed of diagnostic tests, as well as reduce costs and increase patient convenience.
Recommendations and Challenges:
Recommendations:
Development of Advanced Urine Testing Technologies: The development of advanced urine testing technologies, such as point-of-care testing and molecular diagnostics, is expected to drive the market growth.
Increased Focus on Urine-Based Diagnostics for Infectious Diseases: The increasing incidence of infectious diseases, such as UTIs and kidney stones, is expected to drive the demand for urine-based diagnostics.
Growing Demand for Home-Based Urine Testing Kits: The growing demand for home-based urine testing kits for disease diagnosis is expected to drive the market growth.
Increasing Investment in Research and Development: Increasing investment in research and development is expected to drive the development of new and innovative urine IVD products.
Challenges:
Limited Availability of Urine IVD Products: The limited availability of urine IVD products, particularly in developing countries, is a major challenge for the market growth.
High Cost of Urine IVD Products: The high cost of urine IVD products is a major barrier to adoption, particularly in developing countries.
Complexity of Urine IVD Testing: The complexity of urine IVD testing, particularly in cases of UTIs and kidney stones, is a major challenge for healthcare providers.
Regulatory Challenges: Regulatory challenges, such as obtaining regulatory approvals and compliance with regulatory requirements, are a major challenge for the market growth.
Segmentation by type
Consumables
Equipment
Segmentation by application
Drug Testing
Infectious Disease Testing
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Urine in Vitro Diagnostics Market Size 2019-2030
- 2.1.2 Urine in Vitro Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
- 2.2 Urine in Vitro Diagnostics Segment by Type
- 2.2.1 Consumables
- 2.2.2 Equipment
- 2.3 Urine in Vitro Diagnostics Market Size by Type
- 2.3.1 Urine in Vitro Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Urine in Vitro Diagnostics Market Size Market Share by Type (2019-2024)
- 2.4 Urine in Vitro Diagnostics Segment by Application
- 2.4.1 Drug Testing
- 2.4.2 Infectious Disease Testing
- 2.4.3 Other
- 2.5 Urine in Vitro Diagnostics Market Size by Application
- 2.5.1 Urine in Vitro Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Urine in Vitro Diagnostics Market Size Market Share by Application (2019-2024)
- 3 Urine in Vitro Diagnostics Market Size by Player
- 3.1 Urine in Vitro Diagnostics Market Size Market Share by Players
- 3.1.1 Global Urine in Vitro Diagnostics Revenue by Players (2019-2024)
- 3.1.2 Global Urine in Vitro Diagnostics Revenue Market Share by Players (2019-2024)
- 3.2 Global Urine in Vitro Diagnostics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Urine in Vitro Diagnostics by Regions
- 4.1 Urine in Vitro Diagnostics Market Size by Regions (2019-2024)
- 4.2 Americas Urine in Vitro Diagnostics Market Size Growth (2019-2024)
- 4.3 APAC Urine in Vitro Diagnostics Market Size Growth (2019-2024)
- 4.4 Europe Urine in Vitro Diagnostics Market Size Growth (2019-2024)
- 4.5 Middle East & Africa Urine in Vitro Diagnostics Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Urine in Vitro Diagnostics Market Size by Country (2019-2024)
- 5.2 Americas Urine in Vitro Diagnostics Market Size by Type (2019-2024)
- 5.3 Americas Urine in Vitro Diagnostics Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Urine in Vitro Diagnostics Market Size by Region (2019-2024)
- 6.2 APAC Urine in Vitro Diagnostics Market Size by Type (2019-2024)
- 6.3 APAC Urine in Vitro Diagnostics Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Urine in Vitro Diagnostics by Country (2019-2024)
- 7.2 Europe Urine in Vitro Diagnostics Market Size by Type (2019-2024)
- 7.3 Europe Urine in Vitro Diagnostics Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Urine in Vitro Diagnostics by Region (2019-2024)
- 8.2 Middle East & Africa Urine in Vitro Diagnostics Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Urine in Vitro Diagnostics Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Urine in Vitro Diagnostics Market Forecast
- 10.1 Global Urine in Vitro Diagnostics Forecast by Regions (2025-2030)
- 10.1.1 Global Urine in Vitro Diagnostics Forecast by Regions (2025-2030)
- 10.1.2 Americas Urine in Vitro Diagnostics Forecast
- 10.1.3 APAC Urine in Vitro Diagnostics Forecast
- 10.1.4 Europe Urine in Vitro Diagnostics Forecast
- 10.1.5 Middle East & Africa Urine in Vitro Diagnostics Forecast
- 10.2 Americas Urine in Vitro Diagnostics Forecast by Country (2025-2030)
- 10.2.1 United States Urine in Vitro Diagnostics Market Forecast
- 10.2.2 Canada Urine in Vitro Diagnostics Market Forecast
- 10.2.3 Mexico Urine in Vitro Diagnostics Market Forecast
- 10.2.4 Brazil Urine in Vitro Diagnostics Market Forecast
- 10.3 APAC Urine in Vitro Diagnostics Forecast by Region (2025-2030)
- 10.3.1 China Urine in Vitro Diagnostics Market Forecast
- 10.3.2 Japan Urine in Vitro Diagnostics Market Forecast
- 10.3.3 Korea Urine in Vitro Diagnostics Market Forecast
- 10.3.4 Southeast Asia Urine in Vitro Diagnostics Market Forecast
- 10.3.5 India Urine in Vitro Diagnostics Market Forecast
- 10.3.6 Australia Urine in Vitro Diagnostics Market Forecast
- 10.4 Europe Urine in Vitro Diagnostics Forecast by Country (2025-2030)
- 10.4.1 Germany Urine in Vitro Diagnostics Market Forecast
- 10.4.2 France Urine in Vitro Diagnostics Market Forecast
- 10.4.3 UK Urine in Vitro Diagnostics Market Forecast
- 10.4.4 Italy Urine in Vitro Diagnostics Market Forecast
- 10.4.5 Russia Urine in Vitro Diagnostics Market Forecast
- 10.5 Middle East & Africa Urine in Vitro Diagnostics Forecast by Region (2025-2030)
- 10.5.1 Egypt Urine in Vitro Diagnostics Market Forecast
- 10.5.2 South Africa Urine in Vitro Diagnostics Market Forecast
- 10.5.3 Israel Urine in Vitro Diagnostics Market Forecast
- 10.5.4 Turkey Urine in Vitro Diagnostics Market Forecast
- 10.5.5 GCC Countries Urine in Vitro Diagnostics Market Forecast
- 10.6 Global Urine in Vitro Diagnostics Forecast by Type (2025-2030)
- 10.7 Global Urine in Vitro Diagnostics Forecast by Application (2025-2030)
- 11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Roche Company Information
- 11.1.2 Roche Urine in Vitro Diagnostics Product Offered
- 11.1.3 Roche Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Roche Main Business Overview
- 11.1.5 Roche Latest Developments
- 11.2 Siemens
- 11.2.1 Siemens Company Information
- 11.2.2 Siemens Urine in Vitro Diagnostics Product Offered
- 11.2.3 Siemens Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 Siemens Main Business Overview
- 11.2.5 Siemens Latest Developments
- 11.3 Abbott
- 11.3.1 Abbott Company Information
- 11.3.2 Abbott Urine in Vitro Diagnostics Product Offered
- 11.3.3 Abbott Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Abbott Main Business Overview
- 11.3.5 Abbott Latest Developments
- 11.4 Danaher
- 11.4.1 Danaher Company Information
- 11.4.2 Danaher Urine in Vitro Diagnostics Product Offered
- 11.4.3 Danaher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 Danaher Main Business Overview
- 11.4.5 Danaher Latest Developments
- 11.5 Thermo Fisher
- 11.5.1 Thermo Fisher Company Information
- 11.5.2 Thermo Fisher Urine in Vitro Diagnostics Product Offered
- 11.5.3 Thermo Fisher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 Thermo Fisher Main Business Overview
- 11.5.5 Thermo Fisher Latest Developments
- 11.6 BioMerieux
- 11.6.1 BioMerieux Company Information
- 11.6.2 BioMerieux Urine in Vitro Diagnostics Product Offered
- 11.6.3 BioMerieux Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 BioMerieux Main Business Overview
- 11.6.5 BioMerieux Latest Developments
- 11.7 Bio-Rad
- 11.7.1 Bio-Rad Company Information
- 11.7.2 Bio-Rad Urine in Vitro Diagnostics Product Offered
- 11.7.3 Bio-Rad Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 Bio-Rad Main Business Overview
- 11.7.5 Bio-Rad Latest Developments
- 11.8 BD
- 11.8.1 BD Company Information
- 11.8.2 BD Urine in Vitro Diagnostics Product Offered
- 11.8.3 BD Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 BD Main Business Overview
- 11.8.5 BD Latest Developments
- 11.9 KHB
- 11.9.1 KHB Company Information
- 11.9.2 KHB Urine in Vitro Diagnostics Product Offered
- 11.9.3 KHB Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 KHB Main Business Overview
- 11.9.5 KHB Latest Developments
- 11.10 Daan Gene
- 11.10.1 Daan Gene Company Information
- 11.10.2 Daan Gene Urine in Vitro Diagnostics Product Offered
- 11.10.3 Daan Gene Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 Daan Gene Main Business Overview
- 11.10.5 Daan Gene Latest Developments
- 11.11 Leadman
- 11.11.1 Leadman Company Information
- 11.11.2 Leadman Urine in Vitro Diagnostics Product Offered
- 11.11.3 Leadman Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 Leadman Main Business Overview
- 11.11.5 Leadman Latest Developments
- 11.12 Zhongsheng
- 11.12.1 Zhongsheng Company Information
- 11.12.2 Zhongsheng Urine in Vitro Diagnostics Product Offered
- 11.12.3 Zhongsheng Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 Zhongsheng Main Business Overview
- 11.12.5 Zhongsheng Latest Developments
- 11.13 Bsbe
- 11.13.1 Bsbe Company Information
- 11.13.2 Bsbe Urine in Vitro Diagnostics Product Offered
- 11.13.3 Bsbe Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 Bsbe Main Business Overview
- 11.13.5 Bsbe Latest Developments
- 11.14 Maccura
- 11.14.1 Maccura Company Information
- 11.14.2 Maccura Urine in Vitro Diagnostics Product Offered
- 11.14.3 Maccura Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.14.4 Maccura Main Business Overview
- 11.14.5 Maccura Latest Developments
- 11.15 Hitachi
- 11.15.1 Hitachi Company Information
- 11.15.2 Hitachi Urine in Vitro Diagnostics Product Offered
- 11.15.3 Hitachi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.15.4 Hitachi Main Business Overview
- 11.15.5 Hitachi Latest Developments
- 11.16 Canon
- 11.16.1 Canon Company Information
- 11.16.2 Canon Urine in Vitro Diagnostics Product Offered
- 11.16.3 Canon Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.16.4 Canon Main Business Overview
- 11.16.5 Canon Latest Developments
- 11.17 Sysmex
- 11.17.1 Sysmex Company Information
- 11.17.2 Sysmex Urine in Vitro Diagnostics Product Offered
- 11.17.3 Sysmex Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.17.4 Sysmex Main Business Overview
- 11.17.5 Sysmex Latest Developments
- 11.18 Auto Bio
- 11.18.1 Auto Bio Company Information
- 11.18.2 Auto Bio Urine in Vitro Diagnostics Product Offered
- 11.18.3 Auto Bio Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.18.4 Auto Bio Main Business Overview
- 11.18.5 Auto Bio Latest Developments
- 11.19 Mindray
- 11.19.1 Mindray Company Information
- 11.19.2 Mindray Urine in Vitro Diagnostics Product Offered
- 11.19.3 Mindray Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.19.4 Mindray Main Business Overview
- 11.19.5 Mindray Latest Developments
- 11.20 Bgi
- 11.20.1 Bgi Company Information
- 11.20.2 Bgi Urine in Vitro Diagnostics Product Offered
- 11.20.3 Bgi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.20.4 Bgi Main Business Overview
- 11.20.5 Bgi Latest Developments
- 11.21 Wondfo
- 11.21.1 Wondfo Company Information
- 11.21.2 Wondfo Urine in Vitro Diagnostics Product Offered
- 11.21.3 Wondfo Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
- 11.21.4 Wondfo Main Business Overview
- 11.21.5 Wondfo Latest Developments
- 12 Research Findings and Conclusion
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization.png "Nikita Jabrela")
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (16 March, 2025)
- Notify To Team (16 March, 2025)
- Report updation (17 March, 2025)
- Report Quality Check (17 March, 2025)
- Report Dispatch (18 March, 2025)
- Hard Copy
Recently Viewed Products
Global Urine in Vitro Diagnostics Market Growth (Status and Outlook) 2024-2030
We are friendly and approachable, give us a call.